Additionally, tumor grade correlates negatively with receptor abundance (Song et al., 2016; Wang et al., 2017), and, hence, a positive association with patient outcomes has been demonstrated for SST5 (Song et al., 2016; Wang et al., 2017). This evidence concerns the gene SSTR5 and neoplasm.